News

Dravet Caregivers Need Enhanced Support, Recent Survey Shows

Caring for patients with Dravet syndrome places significant physical, emotional and time burdens on caregivers. Supportive services for Dravet families are necessary to improve not only the patients’ outcomes, but also to enhance caregivers’ quality of life, according to a recent survey. The study, “Assessing the impact of…

Levetiracetam More Effective than Phenobarbital in Treating Seizures, Study Suggests

Levetiracetam (marketed as Keppra), an anti-epileptic therapy, is significantly more effective than phenobarbital medication in infants with epilepsy, a recent study found, which could have implications for patients with Dravet syndrome. In the study, “Comparative Effectiveness of Levetiracetam vs Phenobarbital for Infantile Epilepsy,” published in JAMA Pediatrics, scientists…

Stiripentol Combined With Other Antiepileptic Therapies Has Long-term Effectiveness, Study Says

Stiripentol combined with two other antiepileptic medicines seems to be an effective strategy to improve long-term seizure frequency in Dravet syndrome patients. The study that contains that finding, “Stiripentol efficacy and safety in Dravet syndrome: a 12-year observational study” was published in the journal Developmental Medicine & Child Neurology.